N.G. SHAMSUTDINOVA¹, E.S. ZAMANOVA¹, E.V. DYAKOVA², V.I. ILYINSKIY²

¹Kazan State Medical University, 49 Butlerov Str., Kazan, Russian Federation, 420012

²Republican Clinical Hospital of the MH of RT, 138 Orenburgskiy Trakt, Kazan, Russian Federation, 420064 

Shamsutdinova N. G. ― Cand. Med. Sc., Assistant of the Department of Hospital Therapy, tel. (843) 237-36-18, e-mail: nailya@e-diva.ru

Zamanova E. S. ― resident doctor of the Department of Hospital Therapy, tel. +7-927-240-58-10, e-mail: endzhe.zamanova@mail.ru

Dyakova E.V. ― doctor of Pulmonology Department, tel. (843) 231-21-58, +7-917-266-79-93, e-mail: nailya@e-diva.ru

Ilinskiy V.I. ― Head of Pulmonology Department, tel. (843) 231-21-58, e-mail: nailya@e-diva.ru

Lung involvement on patients with rheumatic diseases occurs in 15-50% depending on the form of disease and is characterized by the involvement of airways, blood vessels, alveoli, interstitial, and pleura. The article describes the clinical variants of lung disease in patients with common rheumatic diseases — systemic sclerosis and rheumatoid arthritis.

Key words: interstitial lung disease, rheumatoid arthritis, systemic scleroderma.

REFERENCES

1. Sigidin Ya.A. et al. Revmatoidnyy artrit [Rheumatoid arthritis]. Moscow: ANKO, 2001. 325 p.
2. Sil’vestrov V.P. et al. Possible respiratory lesions in rheumatoid arthritis. Kremlevskaya meditsina, 1999, no. 4, pp. 12-14 (in Russ.).
3. American Thoracic Society statement. Lung function testing: selection of reference values and interpretative strategies. Am. Rev. Respir. Dis, 1991, vol. 144, pp. 1202-1218
4. Abraham D.J., Varga J. Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol, 2005, 26 (11), pp. 587-95.
5. Chizzolini C. T Cells, B Cells and Polarized Immune Response in the Pathogenesis of Fibrosis and Systemic Sclerosis. Curr. Opin. Rheumatol, 2008, 20 (6), pp. 707-12.
6. Gu Y.S., Kong J., Cheema G.S. et al. The immunobiology of systemic sclerosis. Semin. Arthritis. Rheum, 2008, 38 (2), pp. 132-60.
7. Hunzelmann N., Brinckmann J. What are the milestones in the pathogenesis of systemic sclerosis? Ann. Rheum. Dis, 2010, 69, suppl 1, pp. i52-i56.
8. Tanaka N., Kim J.S., Newell J.D. et al. Rheumatoid arthritisrelated lung diseases: CT findings. Radiology, 2004, 232, pp. 81-91.
9. Biederer J., Schnabel A., Muhle C. et al. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. Eur. Radiol, 2004, 14, pp. 272-80.
10. Akira M., Sakatani M., Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J. Comput. Assist. Tomogr, 1999, 23, pp. 941-8.